Endocrine Abstracts

Background: Dopamine agonists (DA) remain the first-line medical therapy for prolactinomas and idiopathic hyperprolactinemia in Endocrinology. DA can also be efficacious in a selected group of patients with acromegaly. There is increasing awareness, among endocrinologists, of Impulse Control Disorders (ICDs) as possible adverse effects of DA therapy.Case reports: We describe ICDs in four patients (two diagnosed with prolactinoma and two diagnosed with ac...